Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
National PeroxideBOM:544205 -1.23%14 EBITDA Margin % is 18.98% as of Mar. 2026, which is 49% above its 10-year median of 12.78. GuruFocus rates BOM:544205 with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 1,578 Chemicals companies, National Peroxide ranks better than 60.84% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. National Peroxide's EBITDA for the
three
months ended in Mar. 2026 was ₹163 Mil. National Peroxide's Revenue for the
three
months ended in Mar. 2026 was ₹857 Mil. Therefore, National Peroxide's EBITDA margin for the quarter that ended in Mar. 2026 was 18.98%.
National Peroxide (BOM:544205) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
National Peroxide EBITDA Margin % Related Terms
National Peroxide EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for National Peroxide's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544205 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, National Peroxide's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Peroxide EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, National Peroxide's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where National Peroxide's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
National Peroxide (BOM:544205) has a EBITDA Margin % of 18.98% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on National Peroxide and its competitors. This is 49% above median its historical median of 12.78. Over the past decade, National Peroxide's EBITDA Margin % has ranged from 6.87 to 20.81. According to the industry distribution chart, National Peroxide ranks #618 out of 1578 companies in the Chemicals industry, placing it in the top 39.2%.
Is National Peroxide's EBITDA Margin % too high?
National Peroxide's current EBITDA Margin % of 18.98% is 49% above median its 10-year median of 12.78. Over the past 10 years, this metric has ranged from a low of 6.87 to a high of 20.81. The Chemicals industry median EBITDA Margin % is 9.68. National Peroxide's value of 18.98% is 96.1% above this industry median. Based on the distribution chart, National Peroxide ranks #618 out of 1578 companies in the Chemicals industry, which is above the industry midpoint. Overall, National Peroxide has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does National Peroxide's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, National Peroxide ranks #618 out of 1578 companies for EBITDA Margin %. This puts National Peroxide in the upper half of its industry. The industry median EBITDA Margin % is 9.68. National Peroxide's value of 18.98% is 96.1% above this benchmark. Historically, National Peroxide's own EBITDA Margin % has ranged from 6.87 to 20.81 over the past decade. While the company's 10-year median is 12.78 vs. the industry median of 9.68, National Peroxide has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.68, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. National Peroxide's current EBITDA Margin % of 18.98% is 96.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on National Peroxide and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. National Peroxide's current EBITDA Margin % is 18.98%, which is 49% above median its own 10-year median of 12.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Peroxide stock overvalued right now?
National Peroxide (BOM:544205) has a current EBITDA Margin % of 18.98%. The current EBITDA Margin % is 18.98%, which is 49% above median its 10-year median of 12.78 and 96.1% above the Chemicals industry median of 9.68. National Peroxide's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For National Peroxide (BOM:544205), the current EBITDA Margin % is 18.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
National Peroxide Ltd is a company that manufactures Hydrogen Peroxide. The company also produces Compressed Hydrogen Gas and Peracetic Acid. The company is engaged in only one segment viz Manufacturing of peroxygens. It generates the majority of its revenue from within India.
14GF Score
Get the complete analysis for BOM:544205
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544205 has been successfully added to your 
